JP2022506749A5 - - Google Patents
Info
- Publication number
- JP2022506749A5 JP2022506749A5 JP2021524328A JP2021524328A JP2022506749A5 JP 2022506749 A5 JP2022506749 A5 JP 2022506749A5 JP 2021524328 A JP2021524328 A JP 2021524328A JP 2021524328 A JP2021524328 A JP 2021524328A JP 2022506749 A5 JP2022506749 A5 JP 2022506749A5
- Authority
- JP
- Japan
- Prior art keywords
- item
- composition
- crosslinkable
- entity
- use according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024184029A JP2025011292A (ja) | 2018-11-02 | 2024-10-18 | 架橋される材料 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862754995P | 2018-11-02 | 2018-11-02 | |
| US62/754,995 | 2018-11-02 | ||
| PCT/US2019/059553 WO2020093022A1 (en) | 2018-11-02 | 2019-11-01 | Crosslinked materials |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024184029A Division JP2025011292A (ja) | 2018-11-02 | 2024-10-18 | 架橋される材料 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022506749A JP2022506749A (ja) | 2022-01-17 |
| JP2022506749A5 true JP2022506749A5 (enExample) | 2022-11-09 |
Family
ID=68655736
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021524328A Pending JP2022506749A (ja) | 2018-11-02 | 2019-11-01 | 架橋される材料 |
| JP2024184029A Pending JP2025011292A (ja) | 2018-11-02 | 2024-10-18 | 架橋される材料 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024184029A Pending JP2025011292A (ja) | 2018-11-02 | 2024-10-18 | 架橋される材料 |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US12311048B2 (enExample) |
| EP (1) | EP3873431A1 (enExample) |
| JP (2) | JP2022506749A (enExample) |
| KR (2) | KR102850634B1 (enExample) |
| CN (1) | CN113365602A (enExample) |
| CA (1) | CA3118491A1 (enExample) |
| SG (1) | SG11202109443QA (enExample) |
| WO (1) | WO2020093022A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG11202109443QA (en) | 2018-11-02 | 2021-09-29 | Fount Bio Inc | Crosslinked materials |
| BR112021020951A2 (pt) * | 2019-04-19 | 2021-12-14 | Fount Bio Inc | Dispensação e retenção de agentes ativos dentro da pele |
| DE102020125546A1 (de) | 2020-09-30 | 2022-03-31 | Leibniz-Institut Für Neue Materialien Gemeinnützige Gesellschaft Mit Beschränkter Haftung | Neuartige Hydrogele |
| WO2022094002A1 (en) * | 2020-10-28 | 2022-05-05 | Fount Bio, Inc. | Transdermal delivery |
| WO2024215742A1 (en) * | 2023-04-11 | 2024-10-17 | The Board Of Trustees Of The University Of Illinois | Phase change materials with enhanced thermal stability |
| EP4724107A2 (en) * | 2023-06-08 | 2026-04-15 | Fount Bio, Inc. | Ophthalmic films |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9902652D0 (en) | 1999-02-05 | 1999-03-31 | Fermentech Med Ltd | Process |
| US8038991B1 (en) * | 2003-04-15 | 2011-10-18 | Abbott Cardiovascular Systems Inc. | High-viscosity hyaluronic acid compositions to treat myocardial conditions |
| FR2857266B1 (fr) | 2003-07-07 | 2007-09-21 | Jean Noel Thorel | Composition a usage dermatologique et/ou cosmetique, comprenant a titre de principe actif au moins un antioxydant lipophile |
| US20060008428A1 (en) | 2004-06-16 | 2006-01-12 | L'oreal | Method of promoting the penetration of a cosmetic active and composition therefore |
| KR20080047395A (ko) | 2005-08-25 | 2008-05-28 | 다이호야쿠힌고교 가부시키가이샤 | Ｔ세포 인식 에피토프 펩티드를 고정화 또는 내포화한생분해성 나노입자 |
| AU2006320556A1 (en) | 2005-12-01 | 2007-06-07 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Isotopically-labeled benzothiazole compounds as imaging agents for amyloidogenic proteins |
| US7750106B2 (en) * | 2005-12-21 | 2010-07-06 | Avon Products, Inc. | Cosmetic compositions having in-situ hydrosilylation cross-linking |
| TWI436793B (zh) * | 2006-08-02 | 2014-05-11 | 巴克斯特國際公司 | 快速作用之乾密封膠及其使用和製造方法 |
| EP3456749B1 (en) * | 2008-02-29 | 2021-07-14 | PVAC Medical Technologies Ltd. | A substituted polyvinyl alcohol reagent |
| JP5905402B2 (ja) | 2010-03-11 | 2016-04-20 | プロメガ コーポレイションＰｒｏｍｅｇａ Ｃｏｒｐｏｒａｔｉｏｎ | シアノベンゾチアゾール化合物を使用する生物発光アッセイ |
| US8735386B2 (en) | 2010-07-23 | 2014-05-27 | Boehringer Ingelheim International Gmbh | Aminopyrazoloquinazolines |
| WO2012165462A1 (ja) | 2011-05-31 | 2012-12-06 | 国立大学法人 東京大学 | ハイドロゲル及びその製造方法 |
| US20130096081A1 (en) * | 2011-06-03 | 2013-04-18 | Allergan, Inc. | Dermal filler compositions |
| US9655967B2 (en) * | 2011-12-09 | 2017-05-23 | The Board Of Trustees Of The Leland Stanford Junior University | Inhibition of focal adhesion kinase for control of scar tissue formation |
| US9096586B2 (en) | 2012-04-20 | 2015-08-04 | Gilead Sciences, Inc. | Therapeutic compounds |
| EP2719703A1 (en) | 2012-10-12 | 2014-04-16 | Ecole Polytechnique Fédérale de Lausanne (EPFL) | Precursor molecule for the synthesis of D-luciferin |
| US20140227174A1 (en) | 2013-02-11 | 2014-08-14 | The Regents Of The University Of California | Skin permeating and cell entering (space) peptides and methods of use therefor |
| US10624865B2 (en) | 2013-03-14 | 2020-04-21 | Pathak Holdings Llc | Methods, compositions, and devices for drug/live cell microarrays |
| WO2014178878A1 (en) | 2013-05-03 | 2014-11-06 | Yale University | Synthetic antibody mimetic compounds (syams) targeting cancer, especially prostate cancer |
| US9932333B2 (en) | 2014-07-16 | 2018-04-03 | Japan Science And Technology Agency | Benzothiazole compound and medicine containing same |
| WO2016201382A1 (en) | 2015-06-11 | 2016-12-15 | The Regents Of The University Of California | Novel hyaluronic acid-based hydrogels having medical applications |
| ES2968013T3 (es) | 2016-03-30 | 2024-05-06 | Convatec Technologies Inc | Apósitos para heridas modificados |
| US20170348218A1 (en) * | 2016-06-03 | 2017-12-07 | Sanova Bioscience Inc | Microneedle patch containing hyaluronic acid for cosmetic use |
| SG11202109443QA (en) | 2018-11-02 | 2021-09-29 | Fount Bio Inc | Crosslinked materials |
| BR112021020951A2 (pt) | 2019-04-19 | 2021-12-14 | Fount Bio Inc | Dispensação e retenção de agentes ativos dentro da pele |
| WO2022094002A1 (en) | 2020-10-28 | 2022-05-05 | Fount Bio, Inc. | Transdermal delivery |
-
2019
- 2019-11-01 SG SG11202109443QA patent/SG11202109443QA/en unknown
- 2019-11-01 KR KR1020217016815A patent/KR102850634B1/ko active Active
- 2019-11-01 KR KR1020257027900A patent/KR20250133796A/ko active Pending
- 2019-11-01 WO PCT/US2019/059553 patent/WO2020093022A1/en not_active Ceased
- 2019-11-01 US US17/289,468 patent/US12311048B2/en active Active
- 2019-11-01 EP EP19809323.9A patent/EP3873431A1/en active Pending
- 2019-11-01 CN CN201980087529.2A patent/CN113365602A/zh active Pending
- 2019-11-01 CA CA3118491A patent/CA3118491A1/en active Pending
- 2019-11-01 JP JP2021524328A patent/JP2022506749A/ja active Pending
-
2024
- 2024-10-18 JP JP2024184029A patent/JP2025011292A/ja active Pending
-
2025
- 2025-04-24 US US19/188,920 patent/US20250312265A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Yu et al. | Polymer microneedles fabricated from alginate and hyaluronate for transdermal delivery of insulin | |
| Yao et al. | Flexible two-layer dissolving and safing microneedle transdermal of neurotoxin: A biocomfortable attempt to treat Rheumatoid Arthritis | |
| Zhang et al. | Poly (ester amide)-based hybrid hydrogels for efficient transdermal insulin delivery | |
| JP6997470B2 (ja) | ガロール基で修飾されたヒアルロン酸誘導体を基材とするヒドロゲルおよびその用途 | |
| Yu et al. | Systematic comparisons of dissolving and swelling hyaluronic acid microneedles in transdermal drug delivery | |
| Cheng et al. | Neural stem cells encapsulated in a functionalized self-assembling peptide hydrogel for brain tissue engineering | |
| Aghmiuni et al. | Quince seed mucilage-based scaffold as a smart biological substrate to mimic mechanobiological behavior of skin and promote fibroblasts proliferation and h-ASCs differentiation into keratinocytes | |
| US20200353127A1 (en) | Collagen peptide-containing polycaprolactone microsphere filler and preparation method therefor | |
| Lee et al. | In situ self-cross-linkable, long-term stable hyaluronic acid filler by gallol autoxidation for tissue augmentation and wrinkle correction | |
| AU2012247089B2 (en) | Microneedle assembly formulation for skin treatment | |
| US20250325638A1 (en) | Vivo synthesis of elastic fiber | |
| Jin et al. | Polyphenol-mediated hyaluronic acid/tannic acid hydrogel with short gelation time and high adhesion strength for accelerating wound healing | |
| Maghdouri-White et al. | Mammary epithelial cell adhesion, viability, and infiltration on blended or coated silk fibroin–collagen type I electrospun scaffolds | |
| KR101967153B1 (ko) | 주름과 피부 결손 및 위축성 흉터 개선을 위한 필러 배합 조성물 | |
| KR101926751B1 (ko) | 피부 충진용 필러 및 이의 제조방법 | |
| CN107814853A (zh) | 适合用于美容和药物用途的外用透皮糖胺聚糖制剂 | |
| Men et al. | Microneedle patch-assisted transdermal administration of recombinant hirudin for the treatment of thrombotic diseases | |
| Goonoo | Tunable biomaterials for myocardial tissue regeneration: promising new strategies for advanced biointerface control and improved therapeutic outcomes | |
| Yoon et al. | Differential regeneration of myocardial infarction depending on the progression of disease and the composition of biomimetic hydrogel | |
| CN104921961B (zh) | 一种多效修复的可降解生物微针贴 | |
| CN110691579A (zh) | 用于治疗的肉毒杆菌神经毒素 | |
| CN113365602A (zh) | 交联材料 | |
| Si et al. | Control-released basic fibroblast growth factor-loaded poly-lactic-co-glycolic acid microspheres promote sciatic nerve regeneration in rats | |
| Zhang et al. | Microneedle drug delivery system based on hyaluronic acid for improving therapeutic efficiency of hypertrophic scars | |
| KR20180035032A (ko) | 가교 히알루론산을 포함하는 주사용 조성물 |